SOL 257
Alternative Names: SOL-257Latest Information Update: 05 Oct 2023
Price :
$50 *
At a glance
- Originator SOLA Biosciences
- Class Antidementias; Gene therapies
- Mechanism of Action Gene transference; TDP-43 protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Amyotrophic lateral sclerosis; Frontotemporal dementia